leading glp-1 treatments for diabetes 2025 Pipeline Update: August - Prime Therapeutics Covering GLP-1 Drugs: Employers' Top

Water retention Some puffiness or bloating, especially in hands and face, as IGF-1 causes cells to hold more water

This should combine aerobic conditioning (Zone 2 cardio) to enhance mitochondrial density and cardiovascular health, with progressive resistance training to preserve and build metabolically active lean muscle tissue

1823 Healthy adipocytes secrete matrix proteins and matrix-degrading enzymes, resulting in improved collagen structure

Various populations are being examined, including individuals of different races

N., Khavinson, V

Daewoong Therapeutics (CEO Bokki Kang), a subsidiary of Daewoong Pharmaceutical, has completed preclinical studies and compiled data for a microneedle patch within the Semaglutide series, a GLP-1 analogue, using its proprietary 'CLOPAM' (Closed-Packed Aeroperssured Microneedle) platform